Both studies found significant benefit in the combined therapy group, attributed to the addition of simvastatin, including improvement in hormone levels (testosterone, FSH, LH), lipids, and other measures of disease activity (e.g., hirsutism). The gene discussed is PLOD1; the disease is Hirsutism.